Recent Research Projects by the FDA’s Pharmacology and Toxicology Statistics Team-Reference-Cited by-同舟云学术

Recent Research Projects by the FDA’s Pharmacology and Toxicology Statistics Team

Published:2016 Issue: Volume: Page:295-348
ISSN:1431-8776
Container-title:Nonclinical Statistics for Pharmaceutical and Biotechnology Industries
language:
Short-container-title:

Author:

Lin Karl K.,Jackson Matthew T.,Min Min,Rahman Mohammad Atiar,Thomson Steven F.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-23558-5_12

Reference50 articles.

1. Ahn H, Kodell R (1995) Estimation and testing of tumor incidence rates in experiments lacking cause-of-death data. Biom J 37:745–765

2. Armitage P (1955) Tests for linear trends in proportions and frequencies. Biometrics 11(3): 375–386

3. Bailer AJ, Portier CJ (1988) Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44(2):417–431

4. Baldrick P, Reeve L (2007) Carcinogenicity evaluation: comparison of tumor data from dual control groups in the cd-1 mouse. Toxicol Pathol 35(4):562–575

5. Bergman CL, Adler RR, Morton DG, Regan KS, Yano BL (2003) Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies: a proposal of the society of toxicologic pathology (stp). Toxicol Pathol 31(2):252–253

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical notes on false positive and negative error rates in the evaluation of long-term carcinogenicity bioassays;2022-03-01

2. Comparisons of false negative rates from a trend test alone and from a trend test jointly with a control-high groups pairwise test in the determination of the carcinogenicity of new drugs;Journal of Biopharmaceutical Statistics;2018-05-21